Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: A report of 4 cases

Pediatric Rheumatology

Volumn 10, Issue , 2012, Pages

  Berard, Roberta ^a   Whittemore, Blair ^b   Scuccimarri, Rosie ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Direct antiglobulin test; Isohemagglutinins; Retreatment

Indexed keywords

BLOOD GROUP ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CORONARY ARTERY ANEURYSM; DRUG INDUCED DISEASE; ERYTHEMA; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNOASSAY; IMMUNOTHERAPY; INFANT; MACULOPAPULAR RASH; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 84859731079     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-10-10     Document Type: Article

References (15)

1. Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005, 146:662-667. 10.1016/j.jpeds.2004.12.022, 15870671.
2. Jolles S, Sewell WA, Misbah SA. Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 2005, 142:1-11. 10.1111/j.1365-2249.2005.02834.x, 1809480, 16178850.
3. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion 2003, 43:1460-1480. 10.1046/j.1537-2995.2003.00519.x, 14507280.
4. Nagakawa M, Watanabe N, Okuno M, et al. Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease. Am J Hematol 2000, 63:160-161. 10.1002/(SICI)1096-8652(200003)63:3<160::AID-AJH11>3.0.CO;2-4, 10679809.
5. Comenzo RL, Malachowski ME, Meissner HC, et al. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of IVIG for Kawasaki disease. J Pediatr 1992, 120:926-928. 10.1016/S0022-3476(05)81964-X, 1593353.
6. Hillyer CD, Schwenn MR, Fulton DR, et al. Autoimmune hemolytic anemia in Kawasaki disease: a case report. Transfusion 1990, 30:738-740. 10.1046/j.1537-2995.1990.30891020336.x, 2219263.
7. Gordon DJ, Sloan SR, de Jong JLO. A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin. Am J Hematol 2009, 84(11):771-772. 10.1002/ajh.21544, 19806664.
8. Scuccimarri R, Rohlicek C, Watanabe Duffy KN, et al. Incidence of early cardiac abnormalities in children with Kawasaki Disease treated with low dose aspirin and intravenous immunoglobulin in the acute phase. Arthritis Rheum 2001, 44(9).
9. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulins in immune thrombocytopenia. Lancet 1983, 2:193-195.
10. Kahwaji J, Barker E, Pepkowitz S, et al. Acute hemolysis after high-dose intravenous Immunoglobulin therapy in highly HLA sensitized patients. Clin J Am Soc Nephrol 2009, 4:1993-1997. 10.2215/CJN.04540709, 2798878, 19833910.
11. Pendergrast JM, Pavenski K, Hannach B. Does deficiency of plasma A/B substances increase the risk of IVIG-mediated hemolysis?. Transfusion 2007, 47:S3.
12. Bunin NJ, Caret JL, Sullivan DB. Autoimmune hemolytic anemia in association with Kawasaki disease. Am J Pediatr Hematol Oncol 1986, 8:351-352. 10.1097/00043426-198624000-00019, 3799937.
13. Punzarino V, Estrada J, Benson K, et al. Autoimmune hemolytic anemia after Kawasaki disease in a child. Int J Hematol 1993, 57:259-263.
14. Kessary-Shoham H, Levy Y, Shoenfeld Y, et al. In vivo administration of intravenous immunoglobulin can lead to enhanced erythrocyte sequestration. J Autoimmun 1999, 13:129-135. 10.1006/jaut.1999.0302, 10441177.
15. Saxon B, Hume H, Delage G. Severity of haemolysis following IVIG infusions in Canada. Transfus Med 2007, 17:240.